BamSEC and AlphaSense Join Forces
Learn More

MAP Pharmaceuticals, Inc.

Formerly NASDAQ: MAPP
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 30 pages Tender and Support Agreement
12/34/56
EX-10.41
from 10-K 2 pages First Amendment to Employment Agreement [Signature Page Follows]
12/34/56
EX-10.40
from 10-K 2 pages First Amendment to Severance Agreement [Signature Page Follows]
12/34/56
EX-10.39
from 10-K 2 pages First Amendment to Change in Control Agreement [Signature Page Follows]
12/34/56
EX-10.38
from 10-K 2 pages First Amendment to Change in Control Agreement [Signature Page Follows]
12/34/56
EX-10.37
from 10-K 1 page Amendment No. 1 to Common Stock Purchase Agreement
12/34/56
EX-10.36
from 10-K 2 pages May 15, 2006 Scott Borland [Address] Dear Scott: We Are Pleased to Extend to You This Offer of Employment With MAP Pharmaceuticals, Inc. Under the Following Terms and Conditions. Your Title Will Be Tempo Dhe Program Director, Reporting Directly to Tom Armer, Vice President and Cso. Your Starting Bi-Weekly Compensation Will Be $6538.00, Annualized to $170,000. You Will Also Be Eligible for Map’s Bonus Program, Which Is Currently an Mbo Based Program With a Target of 10%. This Will Be Discussed With You Further by Lynn or Me When You Start Work
12/34/56
EX-10.5
from 10-Q/A 5 pages First Amendment to Collaboration Agreement
12/34/56
EX-10.1
from 10-Q/A 6 pages Fifth Amendment to Lease Agreement
12/34/56
EX-10.1
from 10-Q 6 pages Fifth Amendment to Lease Agreement
12/34/56
EX-10.5
from 10-Q 5 pages First Amendment to Collaboration Agreement
12/34/56
EX-10.29
from 10-K 3 pages Offer Letter - Donald Kellerman
12/34/56
EX-10.2
from 8-K/A 15 pages Co-Promotion Agreement
12/34/56
EX-10.1
from 8-K/A 75 pages Collaboration Agreement by and Among MAP Pharmaceuticals, Inc., Allergan Sales, LLC, Allergan USA, Inc. and Allergan, Inc. January 28, 2011
12/34/56
EX-10.39
from 10-K 7 pages MAP Pharmaceuticals, Inc. 2007 Equity Award Plan Restricted Stock Unit Award Grant Notice
12/34/56
EX-10.1
from 8-K 57 pages Common Stock Purchase Agreement Dated as of November 11, 2009 by and Between MAP Pharmaceuticals, Inc. and Azimuth Opportunity Ltd
12/34/56
EX-10.1
from 10-Q 6 pages Severance Agreement
12/34/56
EX-10.37
from 10-K 2 pages Offer Letter Dated July 5, 2007 - Charlene A. Friedman
12/34/56
EX-10.36
from 10-K 3 pages Via Overnight Mail and Email Elan Drug Delivery, Inc. 3000 Horizon Drive King of Prussia, Pa 19406 Attn: James L. Botkin, President and Chief Executive Officer MAP Pharmaceuticals, Inc. 2400 Bayshore Parkway, Suite 200 Mountain View, Ca 94043 Attn: Timothy S. Nelson, President and Chief Executive Officer Re: Third Amendment to Services Agreement Dear Mr. Botkin and Mr. Nelson
12/34/56
EX-10.35
from 10-K 2 pages Via Overnight Mail and Email Elan Drug Delivery, Inc. 3000 Horizon Drive King of Prussia, Pa 19406 Attn: James L. Botkin, President and Chief Executive Officer MAP Pharmaceuticals, Inc. 2400 Bayshore Parkway, Suite 200 Mountain View, Ca 94043 Attn: Timothy S. Nelson, President and Chief Executive Officer Re: Second Amendment to Services Agreement Dear Mr. Botkin and Mr. Nelson
12/34/56